MEG3 and colorectal carcinoma: Interestingly, our data revealed, for the first time, that Meg3 serves as a critical inhibitor of the malignant proliferation of colonic stem cells, the cell type that is mainly responsible for the majority of CRC development, especially in early stage CRC.